Molecular Diagnostics and Therapy is the recipient of the ‘Diagnostic Chain of the Year – North’ award at the ET Health Healthcare Awards 2026. We are delighted to be awarded this prestigious award and recognised for our hard work and dedication towards our patients. This is an award in recognition of our ongoing endeavours to provide quality diagnostic and nuclear medicine services, while maintaining our emphasis on advanced technology, access, excellence at every touchpoint within the healthcare service, and a patient-centred environment. This is a recognition of the commitment of our doctors, technologists, and healthcare professionals who do everything they can to continually advance the standards of patient care. 

The presentation of this award on 11th September, 2026, in the presence of the Hon'ble Mr. Sonam Wangchuk further enchanted the moment for our association. The opportunity for us to be recognized as one of the best in our field on a platform as prestigious as the ET Health Healthcare Awards is a great milestone on our journey, and it only helps reinforce our vision to make advanced diagnostic services more accessible to patients throughout the region.

As always, at Molecular Diagnostics and Therapy, our research and investment priorities are in advanced diagnostic technologies, comprehensive care delivery solutions, and precision, innovation, and experience for our patients. Whether it is advanced imaging, Digital PET-CT, or nuclear medicine and diagnostic investigations, our goal is to be a reliable healthcare provider, all under one roof. This award is for our whole team and, more significantly, for our patients and families, who entrust us to deliver care and support to them. We continue to work tirelessly to improve the quality of diagnostic health care and to make a difference in the lives of our patients.